All In Biotech

Drug Trial Radar · NCT03700320

Study to Evaluate the Safety and Tolerability of Treatment With Atogepant 60 mg Daily for the Prevention of Migraine in Participants With Episodic Migraine

A Phase 3, Multicenter, Randomized, Open-label Study to Evaluate the Long-term Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants With Episodic Migraine

Last checked: Nov 20, 2026Latest source record: Jun 15, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 744 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

744

Actual

Start

Oct 8, 2018

Primary completion

May 21, 2020

Study completion May 21, 2020

Sponsor

Lead sponsor
AllerganAbbVie (ABBV)
Sponsor type
Industry
First posted
Oct 9, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will evaluate safety and tolerability of treatment with atogepant for the prevention of episodic migraine over the course of one year.

Conditions

  • Episodic Migraine

Interventions

  • Standard of Care (SOC) Migraine Preventive MedicationDrug

    Standard of care medication selected based on investigator's judgement, recognized as safe and effective for the prevention of migraine.

  • AtogepantDrug

    Atogepant tablets taken orally, once daily for 52 weeks.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants With at Least 1 Treatment Emergent Adverse Event (TEAE)Time frame: From first dose up to the end of study (median treatment of 52 weeks) + 4 weeks follow-up

Locations

112 sites in 1 country. Site status is shown where the registry gives one.

  • Clinical Research Advantage, Inc./Simon Williamson Clinic, PC

    Birmingham, Alabama

  • Achieve Clinical Research, LLC

    Birmingham, Alabama

  • Synexus Clinical Research US, Inc./East Valley Family Physicians PLC

    Chandler, Arizona

  • Synexus Clinical Research US, Inc./Desert Clinical Research, LLC

    Mesa, Arizona

  • Synexus Clinical Research US, Inc./Central Phoenix Medical Clinic, LLC

    Phoenix, Arizona

  • Anaheim Clinical Trials, LLC

    Anaheim, California

  • Hope Clinical Research

    Canoga Park, California

  • Pharmacology Research Institute

    Encino, California

  • Sun Valley Research Center, Inc.

    Imperial, California

  • Irvine Center for Clinical Research

    Irvine, California

  • Grossmont Center for Clinical Research

    La Mesa, California

  • Synergy San Diego

    Lemon Grove, California

  • Collaborative Neuroscience Network, LLC.

    Long Beach, California

  • Pharmacology Research Institute

    Los Alamitos, California

  • Pacific Research Partners, LLC

    Oakland, California

  • Excell Research, Inc.

    Oceanside, California

  • Desert Valley Research

    Redlands, California

  • Medical Center for Clinical Research

    San Diego, California

  • California Research Foundation

    San Diego, California

  • Artemis Institute for Clinical Research

    San Marcos, California

  • California Medical Clinic for Headache

    Santa Monica, California

  • Encompass Clinical Research

    Spring Valley, California

  • Synexus Clinical Research US, Inc.

    Vista, California

  • Diablo Clinical Research, Inc

    Walnut Creek, California

  • Delta Waves, Inc.

    Colorado Springs, Colorado

  • Advanced Neurosciences Research, LLC

    Fort Collins, Colorado

  • MD Clinical

    Hallandale, Florida

  • Infinity Clinical Research

    Hollywood, Florida

  • Clinical Neuroscience Solutions

    Jacksonville, Florida

  • Health Awareness, Inc.

    Jupiter, Florida

  • Meridien Research

    Maitland, Florida

  • Well Pharma Medical Research, Corp.

    Miami, Florida

  • Sensible Healthcare LLC

    Ocoee, Florida

  • Clinical Neuroscience Solutions, Inc

    Orlando, Florida

  • Bioclinica Research

    Orlando, Florida

  • Infinity Clinical Research LLC

    Sunrise, Florida

  • Meridien Research

    Tampa, Florida

  • Premiere Research Institute

    West Palm Beach, Florida

  • Palm Beach Research Center

    West Palm Beach, Florida

  • Synexus Clinical Research US, Inc.

    Atlanta, Georgia

Showing 40 of 112 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.